Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsTOPICALStandard

CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE

BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE

Standard Dose
5%;EQ 1% BASE
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE is listed in Drugs@FDA under application 209252 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE Form and strength GEL;TOPICAL - 5%;EQ 1% BASE Sponsor GLENMARK SPECLT Submission history Latest submission status date: 2019-03-14 00:00:00.

Structured Monograph

Clinical summary

Approval overview CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE is listed in Drugs@FDA under application 209252 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE Form and strength GEL;TOPICAL - 5%;EQ 1% BASE Sponsor GLENMARK SPECLT Submission history Latest submission status date: 2019-03-14 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.